Reduction of serum adiponectin levels in metformin group was in accordance with the improvement in CRP levels supporting pro-inflammatory roles of adiponectin in RA and the evidence that metformin has a potential anti-inflammatory effect. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.